While Aquablation® continues to gain traction as a highly effective therapy for benign prostatic hyperplasia (BPH), the Optilume® BPH Catheter System, another innovative treatment option using drug-coated balloon technology moved closer to commercialization, thanks to innovations and research at Mount Sinai.